Blood PressurePub Date : 2026-10-28DOI: 10.1080/08037051.2026.2715847
Xiaorui Yang, Xinyue Huang, Yue Cui, Ke Zhao
{"title":"Impact of artificial intelligence-assisted health management on blood pressure and self-management efficacy in older adults with hypertension.","authors":"Xiaorui Yang, Xinyue Huang, Yue Cui, Ke Zhao","doi":"10.1080/08037051.2026.2715847","DOIUrl":"https://doi.org/10.1080/08037051.2026.2715847","url":null,"abstract":"<p><strong>Purpose: </strong>This paper examined the impacts of artificial intelligence (AI)-assisted health management on blood pressure control and self-management effectiveness in older adults with hypertension.</p><p><strong>Materials and methods: </strong>Two hundred hypertensive patients were randomly assigned to a usual care group (routine health management) or an intervention group (AI-assisted health management, including aspects such as intelligent monitoring, early warning and proactive intervention, among others) (n = 100 each). Primary outcomes included blood pressure control rate (<140/<90 mm Hg) and systolic and diastolic blood pressure (SBP and DBP). Secondary outcomes included improvement in lifestyle behaviors, level of hypertension knowledge awareness, self-management efficacy, medication beliefs, quality of life, and management satisfaction.</p><p><strong>Results: </strong>Following one year intervention, the intervention group demonstrated a higher blood pressure control rate than the usual care group (88.66% vs. 64.89%), along with lower SBP (128.49 ± 6.63 vs. 135.38 ± 7.31 mmHg) and DBP (77.49 ± 6.07 vs. 81.84 ± 5.44 mmHg) (all <i>P</i> < 0.05). Additionally, the intervention group showed superior improvements in smoking behavior change, alcohol consumption behavior change, low-salt and low-fat diet adherence, and regular exercise attainment, as well as higher scores on the Hypertension Knowledge-Level Scale, Hypertension Patient Self-Management Behavior Rating Scale, Modified Beliefs about Medicines Questionnaire, physical component summary and the mental component summary, and Client Satisfaction Questionnaire-8 (all <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>AI-assisted health management enhances blood pressure control, and improves self-management capacity, quality of life, and service satisfaction in older adults with hypertension.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"1-18"},"PeriodicalIF":2.3,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149284931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2026-04-07Epub Date: 2026-05-05DOI: 10.1080/08037051.2026.2656030
Asif Jan, Daniel Dubwa
{"title":"Assessing the Relationship Between Nocturnal Hypertension and the Risk of Cardiovascular Complications: A Systematic Review and Meta-analysis.","authors":"Asif Jan, Daniel Dubwa","doi":"10.1080/08037051.2026.2656030","DOIUrl":"10.1080/08037051.2026.2656030","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide, driven by multifactorial risk factors, including undiagnosed hypertension. Masked nocturnal hypertension (MNH), characterised by elevated night-time BP despite normal daytime levels, has been linked to increased CVD risk and hypertensive target organ damage. This systematic review and meta-analysis aim to synthesise evidence on the relationship between MNH and CVD risk.</p><p><strong>Methods: </strong>A comprehensive search was conducted in PubMed, Web of Science, and Embase for studies published until December 20, 2025. Observational studies reporting associations between MNH and CVD risk with sufficient statistical data for meta-analysis were included. The pooled Hazard ratio (HR) was calculated using a random effect model using R software version 4.4. Heterogeneity was assessed with I<sup>2</sup> and sensitivity analyses were conducted to evaluate robustness. Study quality was assessed using the Newcastle-Ottawa Scale (NOS).</p><p><strong>Results: </strong>Out of 10,521 records screened, 5 studies with a sample size of over 19,000 participants were included. The studies consistently reported a significant association between elevated MNH levels and increased CVD risk. Meta-analysis yielded a pooled HR of 1.471 (95% CI: 1.008-2.147), confirming the association. No heterogeneity was observed (I<b><sup>2</sup></b> = 0%). Sensitivity analysis demonstrated the robustness of the findings.</p><p><strong>Conclusion: </strong>This meta-analysis suggests a positive association between MNH and increased CVD risk, though the limited number of studies warrants caution in over-interpretation. While MNH appears to be a relevant phenotype for cardiovascular risk stratification, further large-scale prospective research is required to confirm the magnitude of this effect and its clinical utility in routine hypertension management.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2656030"},"PeriodicalIF":2.3,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147632298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Malignant hypertension, and if it was scleroderma? Lessons from two cases.","authors":"Réda Laamech, Diane Giovannini, Etienne Cellot, Sandra Jost, Benoit Franko","doi":"10.1080/08037051.2025.2482741","DOIUrl":"10.1080/08037051.2025.2482741","url":null,"abstract":"<p><p><b>Inroduction :</b> Scleroderma Renal Crisis (SRC) is characterised by acute hypertension, haemolytic anaemia (HA), and acute kidney injury (AKI). Often presenting as the first manifestation of scleroderma, it is frequently mistaken for malignant hypertension (MHT). Rapid recognition and differentiation of SRC from other hypertensive emergencies are essential for improving patient outcomes.We present two clinical cases that illustrate the diagnostic challenges of SRC in the context of MHT.</p><p><p><b>Case 1:</b> A 53-year-old man presented with severe hypertension (238/127 mmHg) and AKI (creatinine 390 μmol/L). He was diagnosed MHT due to the presence of grade III hypertensive retinopathy and HA. . However, a urine dipstick test detected haematuria, leading to further immune testing and, a renal biopsy, which confirmed SRC. Treatment with high-dose ramipril led to a sustained recovery of kidney function, 221 μmol/L after five years).</p><p><p><b>Case 2:</b> A 52-year-old man presented with chest pain, severe hypertension (253/132 mmHg), and AKI (creatinine 183 μmol/L). Initially managed as MHT, his kidney function worsened, prompting further investigation, which revealed haematuria and positive anti-nuclear antibodies. A renal biopsy confirmed SRC. High-dose ramipril was reintroduced, leading to partial kidney function recovery (creatinine 218 μmol/L after five years).</p><p><p><b>Key findings :</b> These cases underscore the importance of early detection of hematuria and autoimmune markers to expedite diagnosis of SRC in case of MHT. When SRC is suspected, high-dose angiotensin-converting enzyme inhibitors (ACEi) should be initiated immediately, even before biopsy confirmation and continued despite initial kidney function decline. Early intervention is crucial for optimising kidney outcomes and achieving effective blood pressure control.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2482741"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143661935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-03-17DOI: 10.1080/08037051.2025.2468172
Xiaoling Zhang, Jinhui Wu
{"title":"Temporal trends and relevant factors of hypertension in China: a cross-sectional study based on national surveys from 2002 to 2019.","authors":"Xiaoling Zhang, Jinhui Wu","doi":"10.1080/08037051.2025.2468172","DOIUrl":"10.1080/08037051.2025.2468172","url":null,"abstract":"<p><strong>Purpose: </strong>This study examined temporal trends in hypertension prevalence across China (2002-2019), analyzing age-, sex-, and region-specific disparities and identifying key risk factors.</p><p><strong>Materials and methods: </strong>A retrospective analysis was conducted using data from the China Chronic Disease and Risk Factor Surveillance (CCDRFS) program, involving 120,000 adults aged ≥18 years. Descriptive statistics were used to calculate prevalence rates, and multivariable logistic regression analyzed associations with age, sex, BMI, smoking, alcohol consumption, and physical inactivity.</p><p><strong>Results: </strong>Hypertension prevalence increased significantly from 18.9% (2002) to 29.6% (2019) (P<0.001). The sharpest rise occurred among adults aged 18-44 years, tripling from 5.3% to 12.8%. By 2019, prevalence was higher in men (34.2%) than women (25.4%), with the western regions showing the highest rates (32.9%). Key risk factors included aging (OR=1.72), elevated BMI (OR=1.85), smoking (OR=1.32), alcohol use (OR=1.28), and physical inactivity (OR=1.18) (P<0.05 for all).</p><p><strong>Conclusions: </strong>Hypertension prevalence in China has surged over two decades, disproportionately affecting younger adults and men. Regional disparities and modifiable lifestyle factors underscore the urgency for tailored prevention strategies targeting high-risk populations. Future research should explore mechanisms driving these trends and optimize integrated interventions to curb this public health burden.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2468172"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143646941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-09-16DOI: 10.1080/08037051.2025.2542160
Zheng Tian, Qin Han, Xinyi Liu, Hongyi Zhu, Yimiao Li, Nan Zhang, Liwei Jing, Lan Wang
{"title":"Exploring the impact of short sleep on hypertension prevalence in the Chinese population: dose-response relationships, standardisation, and health behaviours.","authors":"Zheng Tian, Qin Han, Xinyi Liu, Hongyi Zhu, Yimiao Li, Nan Zhang, Liwei Jing, Lan Wang","doi":"10.1080/08037051.2025.2542160","DOIUrl":"10.1080/08037051.2025.2542160","url":null,"abstract":"<p><strong>Aims: </strong>Explore the association between short sleep and hypertension risk in the Chinese population.</p><p><strong>Methods: </strong>Data from the 2020 Chinese Psychological and Behavioural Study of the Population were utilised. Restricted cubic spline models assessed dose-response relationships between sleep duration and hypertension risk. A binary logistic regression model, incorporating propensity score matching, explored the true association between short sleep duration and hypertension risk in the Chinese population. In addition, using binary logistic regression models examined the association between >5 h of sleep and hypertension risks and the impact of health behaviours on hypertension risk among short sleepers.</p><p><strong>Results: </strong>Sleep duration and hypertension risk exhibited a non-linear U-shaped pattern. ≤5-hour sleepers had a 32% reduced hypertension risk per additional hour of sleep post-matching. >5-hour sleep didn't affect hypertension risk. Among ≤5-hour sleepers, smoking and prolonged fixed position work increased hypertension risk by 128 and 103.4%, respectively, while engaging in physical activity for over six months reduced it by 63.7%.</p><p><strong>Conclusion: </strong>The 5-hour sleep threshold represents a significant turning point for hypertension risk in the Chinese population studied and could serve as a criterion for defining short sleep. Lifestyle modifications such as quitting smoking, adjusting posture during work, and maintaining regular exercise routines can mitigate hypertension risk among individuals with short sleep duration.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2542160"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144759065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-07-24DOI: 10.1080/08037051.2025.2535689
Giacomo Buso, Thomas Weber, Christos Fragoulis, Guido Grassi, Claudia Agabiti-Rosei, Christian Delles, Michalis Doumas, Massimo Salvetti, Reinhold Kreutz, Konstantinos Tsioufis, Maria Lorenza Muiesan
{"title":"Diagnostic and therapeutic approach to acute blood pressure elevations: results of an international survey among excellence centres of the European society of hypertension.","authors":"Giacomo Buso, Thomas Weber, Christos Fragoulis, Guido Grassi, Claudia Agabiti-Rosei, Christian Delles, Michalis Doumas, Massimo Salvetti, Reinhold Kreutz, Konstantinos Tsioufis, Maria Lorenza Muiesan","doi":"10.1080/08037051.2025.2535689","DOIUrl":"10.1080/08037051.2025.2535689","url":null,"abstract":"<p><strong>Background: </strong>Acute blood pressure (BP) elevations are common in emergency settings and are traditionally classified into hypertensive urgencies (HU) and hypertensive emergencies (HE). Malignant hypertension (MHT) represents a severe form of HE characterised by small vessel damage. Although international guidelines provide clear definitions and treatment strategies, real-world data have shown persistent fragmentation and heterogeneity in the diagnosis and management of these patients.</p><p><strong>Methods: </strong>A web-based, anonymous survey promoted by the European Society of Hypertension (ESH) was distributed among physicians from 18 European and 4 non-European countries. The questionnaire assessed definitions, diagnostic work-up, BP measurement practices, and therapeutic strategies for HU, HE, and MHT.</p><p><strong>Results: </strong>Sixty-four participants in 56 centres completed the survey. HU was correctly defined as a severe BP elevation without acute clinically symptomatic hypertension-mediated organ damage (A-HMOD) by 45.3% of respondents. Small cuffs were available to 79.7% and extra-large cuffs to 70.3% of respondents.. Intravenous antihypertensive therapy was used for HE by 88.7% of participants, while 20.6% also used intravenous drugs for HU. Parenteral clonidine and sublingual nifedipine were prescribed by 29.7% and 26.6% of respondents, respectively. Definitions and therapeutic approaches for MHT varied substantially, with 62.9% adopting <b>a recently</b> proposed definition involving at least three target organ damages in patients with BP >200/120 mmHg.</p><p><strong>Conclusions: </strong>This international survey highlights considerable variability in the definition, diagnostic work-up, and therapeutic management of acute BP elevations, emphasising the need for harmonised protocols and further education.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"34 1","pages":"2535689"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144706257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-09-03DOI: 10.1080/08037051.2025.2554221
Aiman S Kerimkulova, Viktor R Veber, Akbayan M Markabayeva, Riza G Nurpeissova, Alisher S Idrissov, Ainur S Ospanova, Ainur A Mukhamejanova, Andrej M Grjibovski
{"title":"An autopsy study of right ventricular hypertrophy in relation to left ventricular remodelling in arterial hypertension.","authors":"Aiman S Kerimkulova, Viktor R Veber, Akbayan M Markabayeva, Riza G Nurpeissova, Alisher S Idrissov, Ainur S Ospanova, Ainur A Mukhamejanova, Andrej M Grjibovski","doi":"10.1080/08037051.2025.2554221","DOIUrl":"10.1080/08037051.2025.2554221","url":null,"abstract":"<p><strong>Objectives: </strong>To study the prevalence and severity of right ventricular hypertrophy (RVH) in relation to left ventricular hypertrophy (LVH) among individuals with hypertension during their lifetime using post-mortem examination records.</p><p><strong>Methods: </strong>In total, 647 autopsy protocols for individuals with systematic hypertension during their lifetime were investigated at forensic laboratories in Semey (Kazakhstan). Associations between right ventricular wall thickness (RVWT) and left ventricular wall thickness (LVWT) adjusted for age, sex, and ethnic background were studied using multiple quantile regression. LVH and RVH as categorical variables were analysed using chi-square tests and multivariable Poisson regression. Prevalence ratios (PR) were calculated using 95% confidence intervals (CI) with robust standard errors.</p><p><strong>Results: </strong>The right ventricle hypertrophy during systemic hypertension has been less extensively studied, particularly using post-mortem examination data. The prevalence of LVH and RVH were 100% and 87.2%, respectively. A positive correlation was observed between RVWT and LVWT (<i>r</i> = 0.66, <i>p</i> < 0.001). LVWT was the strongest predictor of RVH (PR = 1.27, 95% CI: 1.19- 1.36). Moreover, male sex (PR = 1.08, 95% CI: 1.01- 1.15) and Russian ethnicity (PR = 1.11, 95% CI: 1.03- 1.20) but not age were associated with RVH in the multivariable model. LVWT was the only significant predictor of RVWT as a continuous dependent variable.</p><p><strong>Conclusions: </strong>Right ventricular hypertrophy is common in hypertension and is more frequent and pronounced among men and ethnic Russians in Eastern Kazakhstan. Our findings corroborate the existing evidence suggesting that remodelling of the left and right ventricles occurs concurrently.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"34 1","pages":"2554221"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144941098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Physical Activity, sleep disorders and hypertension: observational and Mendelian randomization analyses.","authors":"Baizhi Qiu, Qin Wang, Zhishan Ling, Shuyang Wen, Qiuru Yao, Yupeng Xiao, Xiaoyi Xu, Zifan Li, Siying Long, Tingting Yang, Wei Liu, Guozhi Huang, Qing Zeng","doi":"10.1080/08037051.2025.2569387","DOIUrl":"10.1080/08037051.2025.2569387","url":null,"abstract":"<p><strong>Background: </strong>The interrelationships between physical activity (PA), sleep disorders, and hypertension remain incompletely characterised, particularly regarding potential interactions between PA and sleep disorders on hypertension risk. This study aimed to investigate these associations using complementary epidemiological approaches.</p><p><strong>Methods: </strong>We conducted a population-based observational analysis of 18,052 adults aged ≥18 years using data from the National Health and Nutrition Examination Survey, a nationally representative cross-sectional survey (2005-2018). Weighted multivariate logistic regression models were used to examine the associations between PA, sleep disorders, and hypertension, as well as the interaction effect of PA and sleep disorders on hypertension. Additionally, we performed a two-sample Mendelian randomisation (MR) analysis was conducted to assess the causal relationship between PA, sleep disorders, and hypertension.</p><p><strong>Results: </strong>The analysis of observational data shows that sleep disorders are significantly associated with a higher risk of hypertension, with an odds ratio (OR) of 1.61 (95% CI: 1.10-2.35, <i>p</i> = 0.015). Restricted Cubic Spline (RCS) analysis revealed an S-shaped dose-response relationship between PA and hypertension (P-non-linear < 0.001). The MR analysis results were consistent with these findings.</p><p><strong>Conclusions: </strong>Convergent evidence from observational and genetic analyses identified sleep disorders as an independent risk factor for hypertension. The non-monotonic S-shaped association between PA and hypertension underscored the importance of personalised activity prescriptions for cardiovascular risk optimisation. Notably, no significant interaction was observed between PA and sleep disorders, suggesting that their effects on hypertension are likely independent.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2569387"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145211486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-11-13DOI: 10.1080/08037051.2025.2587994
Dirk De Bacquer
{"title":"Author's reply to 'On the use of hospital-based campaign data to evaluate hypertension care cascades'.","authors":"Dirk De Bacquer","doi":"10.1080/08037051.2025.2587994","DOIUrl":"10.1080/08037051.2025.2587994","url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2587994"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145480764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}